2018
Wednesday Wed
Discover how Stanford Medicine is improving the future of your heart and health.
2018 marks the 50th anniversary of the first successful U.S. human heart transplant at Stanford.
Join Dean Lloyd B. Minor, MD, faculty leaders, and friends to celebrate 50 years of success in cardiovascular medicine at Stanford and preview the promise held by exciting new discoveries in predicting, preventing, and treating heart and vascular conditions.
join us
wednesday | april 18
6:00 – 8:00 p.m.
McCaw Hall
Frances C. Arrillaga Alumni Center
326 Galvez Street | Stanford
RSVP by April 6 to Megan O'Connor at 650.736.6687 or megan.oconnor@stanford.edu. Complimentary valet parking will be provided.
McCaw Hall - Frances C. Arrillaga Alumni Center
326 Galvez StreetStanford, CA 94305
program
| 6:00 p.m. | reception |
| 6:30 p.m. | program |
| 7:15 p.m. | innovation stations + faculty Q & A |
Refreshments and heavy hors d’oeuvres will be served.
featured speakers
Welcome and opening remarks
Lloyd Minor, MD
Carl and Elizabeth Naumann Dean of the
School of Medicine
Moderator
Dr. Alan Yeung
Li Ka Shing Professor in Cardiology
Clinical Chief of Cardiovascular Medicine
Your heart: replacement, repair, regeneration
Learn how we’ve gone from replacing hearts and valves or bypassing blood vessels to repairing, regenerating, and reenergizing these organs and tissues through innovative surgical procedures and pushing the boundaries of scientific discovery.
Joseph Woo, MD
Norman E. Shumway Professor and Chair, Department of Cardiothoracic Surgery
Professor, by courtesy, Department of Bioengineering
Q&A: The convergence of technology and care
By harnessing the combined powers of cellular biology, technology, and data science, the ability to better prevent, diagnose, and treat heart disease is in our grasp.
Helen Blau, PhD
Donald E. and Delia B. Baxter Foundation Professor
Director, Baxter Laboratory for Stem Cell Biology
Sanjiv Narayan, MD, PhD
Professor, Cardiovascular Medicine
Co-Director, Stanford Center for Arrhythmia Research
Q&A: Advances in drug development
Imagine a future where cardiac clinical trials can be conducted in a petri dish. Or, where treatment options can be significantly accelerated by using data to uncover ways of repurposing existing therapies. That future is upon us.
Joseph Wu, MD, PhD
Simon H. Stertzer, MD, Professor and Professor of Radiology
Director, Stanford Cardiovascular Institute
Daria Mochly-Rosen, PhD
George D. Smith Professor of Translational Medicine
Founder and President, SPARK Program in Translational Research
The impact of lifestyle and genetics
Could the key to your heart health lie in the device on your wrist? Hear how the combination of wearables, genetic analysis, and artificial intelligence could offer a solution for overcoming heart disease.
Euan Ashley, MD, PhD
Professor, Cardiovascular Medicine
Co-Director, Stanford Clinical Genomics Program
Founding Director, Stanford Center for Inherited Cardiovascular Disease
innovation stations
Transplants, repair, and regeneration
Joseph Woo, MD
The chair of the Department of Cardiothoracic Surgery, Dr Woo’s work focuses on valve repair, stem cell research, and the development of next-generation surgical techniques
Jeffrey E. Cohen, MD
Dr. Cohen is a fellow in the Department of Cardiothoracic Surgery, his research is uncovering ways to use photosynthesis to repair damaged heart tissue.
Kiran Khush, MD
Dr. Khush’s work centers around heart transplant rejection and identifying markers in blood. She is also interested in answering questions of what qualifies a heart as worthy for transplant and why cancer deaths occur in so many transplant survivors.
Ngan Huang, PhD
Professor Huang’s lab is researching how stem cell technologies can be used in muscle and vascular tissue. They are exploring ways to use cell regeneration and cardiac tissue engineering to improve cell survival after aortic aneurysms and coronary artery disease.
Convergence of technology
Helen Blau, PhD
Professor Blau is director of the Baxter Laboratory for Stem Cell Biology, which uses interdisciplinary approaches— incorporating biomaterials, imaging, single cell proteomics, genomics, and tracking—to identify novel therapeutics for rejuvenating muscle stem cell function and regeneration.
Sanjiv Narayan, MD, PhD
Dr. Narayan is co-founder and director of the Stanford Center for Arrhythmia Research and director of the Computational Arrhythmia Research Laboratory. His work applying analytic methods, modeling, and machine learning has led to the development of a novel treatment called Focal Impulse and Rotor Modulation (FIRM) ablation to treat atrial and ventricular fibrillation.
Mintu Turakhia, MD
Dr. Turakhia is a cardiac electrophysiologist and the executive director of the Stanford’s new Center for Digital Health. He is leading several trials testing digital health tools and wearable devices to screen and manage heart rhythm disorders. His research analyzes the connection between biometric data and health.
Alison Marsden, PhD
Professor Marsden is a mechanical engineer who also holds appointments in the departments of Pediatrics and Bioengineering. Her work focuses on the development of novel methods for cardiovascular blood flow simulation, medical device design, and application of engineering tools to impact patient care in cardiovascular surgery and congenital heart disease.
Drug development
Joseph C. Wu, MD, PhD
Dr. Wu is the director of the Stanford Cardiovascular Institute. The Joseph Wu Lab applies a combination of genomics, stem cells, cellular and molecular biology, physiological testing, and imaging technologies to better understand molecular and pathophysiological processes.
Daria Mochly-Rosen, PhD
Professor Mochly-Rosen is the founder of SPARK , a hands-on training program that helps academic researchers translate their discoveries into drugs. SPARK has created unique partnerships between Stanford and industry experts and executives to provide an accelerated path for taking research findings into clinical care for patients.
Marco Perez, MD
Dr. Perez is the director of the Stanford Inherited Arrhythmia Clinic and studies genetics and epidemiology in order to identify the biological and environmental factures associated with atrial fibrillation and heart failure. His research has led to promising novel therapeutic targets, including a cardiac drug developed after discovering that a gene known to contribute to narcolepsy also affects heart failure.
Abha Khandelwal, MD
Dr. Khandelwal’s focus on women’s heart health has led to investigating a novel therapy to limit the production of Lipoprotein(a). One in five people have high levels of LP(a) based on inherited genetic factors and many women experience increased LP(a) levels with age. This increases the risk of atherosclerosis, coronary disease, heart attack, peripheral vascular disease, valve damage, blood clots, and stroke. Other areas of her clinical focus include cardiovascular disease in pregnancy and heart disease in South Asians.
Lifestyle and genetics
Euan Ashley, MD, PhD
Dr. Ashley is co-director of the Stanford Clinical Genomics Program and founding director of the Center for Inherited Cardiovascular Disease. The Ashley Lab studies the human genome and applies data science and machine learning to uncover the effects of genes and proteins on health and diseases like inherited cardiomyopathies. In 2013, Dr. Ashley was recognized by the White House for his contributions to Personalized Medicine.
Josh Knowles, MD, PhD
Dr. Knowles seeks to understand the genetic basis of cardiovascular diseases such as coronary disease and insulin resistance. He also has a strong interest in familial hypercholesterolemia (FH), an inherited disease that causes extremely elevated LDL cholesterol levels and risk of coronary disease. He serves as the chief medical advisor for The FH Foundation, a patient-led, non-profit group that is attempting to raise the profile of familial hypercholesterolemia.
Venita Chandra, MD
Dr. Chandra specializes in cutting-edge approaches to aortic aneurysmal disease, peripheral vascular disease, limb salvaging, and re-vascularization of lower extremities.
Ron Dalman, MD
Dr. Dalman holds the Chidester Professorship in the Department of Surgery. His work uses molecular, imaging and computer modeling to identify and test new treatments for aneurysms, circulatory disorders and limb salvage, both surgically and with drugs. He is also directing several clinical trials.
A legacy of firsts
| 1968 | adult heart transplant in the U.S. |
| 1981 | adult combined heart-lung transplant in the world |
| 1992 | thoracic stent graft in the world |
| 1995 | minimally invasive heart-valve program in the country |